1. Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation. Issue 7 (2nd February 2016) Authors: Hijazi, Ziad; Aulin, Julia; Andersson, Ulrika; Alexander, John H; Gersh, Bernard; Granger, Christopher B; Hanna, Michael; Horowitz, John; Hylek, Elaine M; Lopes, Renato D; Siegbahn, Agneta; Wallentin, Lars Journal: Heart Issue: Volume 102:Issue 7(2016) Page Start: 508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial. Issue 2 (1st November 2018) Authors: Sandhu, Roopinder K; Ezekowitz, Justin A; Hijazi, Ziad; Westerbergh, Johan; Aulin, Julia; Alexander, John H; Granger, Christopher B; Halvorsen, Sigrun; Hanna, Michael S; Lopes, Renato D; Siegbahn, Agneta; Wallentin, Lars Journal: Open heart Issue: Volume 5:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Serial measurement of interleukin‐6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE‐LY trials. (1st August 2020) Authors: Aulin, Julia; Hijazi, Ziad; Siegbahn, Agneta; Andersson, Ulrika; Alexander, John H.; Connolly, Stuart J.; Ezekowitz, Michael D.; Gersh, Bernard J.; Granger, Christopher B.; Horowitz, John; Hylek, Elaine M.; Lopes, Renato D.; Yusuf, Salim; Wallentin, Lars; Oldgren, Jonas Journal: Journal of thrombosis and haemostasis Issue: Volume 18:Number 9(2020) Page Start: 2287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗